Levin Capital Strategies L.P. Sells 93,151 Shares of Kenvue Inc. (NYSE:KVUE)

Levin Capital Strategies L.P. cut its holdings in Kenvue Inc. (NYSE:KVUE) by 79.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,326 shares of the company’s stock after selling 93,151 shares during the quarter. Levin Capital Strategies L.P.’s holdings in Kenvue were worth $524,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Beaumont Financial Advisors LLC lifted its position in Kenvue by 3.0% in the 4th quarter. Beaumont Financial Advisors LLC now owns 17,532 shares of the company’s stock valued at $377,000 after acquiring an additional 509 shares in the last quarter. Pinnacle Bancorp Inc. lifted its holdings in shares of Kenvue by 51.3% during the 4th quarter. Pinnacle Bancorp Inc. now owns 1,552 shares of the company’s stock valued at $33,000 after buying an additional 526 shares during the period. Dfpg Investments LLC lifted its holdings in shares of Kenvue by 2.3% during the 4th quarter. Dfpg Investments LLC now owns 26,659 shares of the company’s stock valued at $567,000 after buying an additional 589 shares during the period. Mutual Advisors LLC lifted its holdings in shares of Kenvue by 6.1% during the 4th quarter. Mutual Advisors LLC now owns 10,606 shares of the company’s stock valued at $228,000 after buying an additional 612 shares during the period. Finally, Baron Wealth Management LLC lifted its holdings in shares of Kenvue by 7.5% during the 4th quarter. Baron Wealth Management LLC now owns 12,915 shares of the company’s stock valued at $278,000 after buying an additional 899 shares during the period. 97.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

KVUE has been the topic of several research analyst reports. Sanford C. Bernstein initiated coverage on Kenvue in a report on Thursday, April 11th. They set an “underperform” rating and a $18.00 price target on the stock. JPMorgan Chase & Co. lowered their price target on Kenvue from $25.00 to $24.00 and set an “overweight” rating on the stock in a report on Friday, February 9th. Royal Bank of Canada decreased their target price on Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, February 9th. The Goldman Sachs Group started coverage on Kenvue in a report on Friday, March 1st. They issued a “neutral” rating and a $20.00 target price on the stock. Finally, William Blair started coverage on Kenvue in a report on Wednesday, April 3rd. They issued a “market perform” rating on the stock. One analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $24.85.

Kenvue Stock Up 1.4 %

NYSE KVUE traded up $0.27 during trading hours on Thursday, hitting $19.12. 10,314,411 shares of the company were exchanged, compared to its average volume of 16,631,246. The stock has a 50-day moving average price of $19.82 and a 200 day moving average price of $20.12. The company has a current ratio of 1.12, a quick ratio of 0.78 and a debt-to-equity ratio of 0.69. Kenvue Inc. has a 52 week low of $17.82 and a 52 week high of $27.80.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, February 8th. The company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.03. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. The company had revenue of $3.67 billion for the quarter, compared to analysts’ expectations of $3.78 billion. The firm’s revenue was down 2.7% compared to the same quarter last year. Research analysts predict that Kenvue Inc. will post 1.15 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Wednesday, May 8th will be paid a dividend of $0.20 per share. The ex-dividend date is Tuesday, May 7th. This represents a $0.80 annualized dividend and a yield of 4.18%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.